Skip to main content

Month: September 2023

Network Monitoring Market to Surpass USD 6.97 Billion by 2030, exhibiting a CAGR of 11.1%

As per the report by Fortune Business Insights, the global network monitoring market size is projected to reach USD 6.97 billion in 2030, at a CAGR of 11.1% during the forecast period, 2023-2030Network Monitoring MarketForecast, 2023 – 2030Pune, India, Sept. 18, 2023 (GLOBE NEWSWIRE) — The network monitoring market size was valued at USD 3.04 billion in 2022 and is projected to reach USD 6.97 billion by 2030, exhibiting a CAGR of 11.1% during the forecast period. Fortune Business Insights presents this information in its latest report titled “Global Network Monitoring Market Forecast, 2023-2030.” Network monitoring helps users to analyze, identify, and monitor different aspects of the local and distributed networks, such as network traffic, bandwidth, network servers, and the health and reliability of the...

Continue reading

Penetration Testing Market Size to Surpass USD 5.10 Billion by 2030, exhibiting a CAGR of 12.8%

As per the report by Fortune Business Insights, the Penetration Testing Market size is projected to reach USD 5.10 Billion in 2030, at a CAGR of 12.8% during the forecast period, 2023-2030Penetration Testing Market2023 – 2030Pune, India, Sept. 18, 2023 (GLOBE NEWSWIRE) — The global penetration testing market size was valued at USD 1.98 billion in 2022 and is projected to reach USD 5.10 billion by 2030, exhibiting a CAGR of 12.8% during the forecast period. Fortune Business Insights presents this information in their report titled “Global Penetration Testing Market Forecast, 2023-2030.”Request a Sample PDF: https://www.fortunebusinessinsights.com/enquiry/sample/penetration-testing-market-108434Penetration testing helps cyber security experts identify and exploit computer system vulnerabilities. This testing...

Continue reading

Veterinary Vaccines Market Size to Surpass USD 15.92 billion by 2030, exhibiting a CAGR of 6.3%

As per the report by Fortune Business Insights, the global Veterinary Vaccines Market size is projected to reach USD 15.92 billion in 2030, at a CAGR of 6.3% during the forecast period, 2023-2030Veterinary Vaccines MarketForecast 2023-2030Pune, India, Sept. 18, 2023 (GLOBE NEWSWIRE) — Global veterinary vaccines market size was valued at USD 9.88 billion in 2022 Industry is expected to expand from USD 15.92 billion by 2030 exhibiting a CAGR of 6.3% over the study period. Technological Development in Animal Immunization to Propel Market Growth, Long-term Protection in Live Attenuated Vaccines to Lead to Segment Growth The market expansion can be credited to the increased pet care spending. People have become more aware of animal healthcare and the implications of its neglect. Fortune Business Insights™ provides this...

Continue reading

Novaturas to buy back and distribute almost 76,000 of its shares to employees for EUR 0.25 million

Novaturas, the largest tour operator in the Baltics, has announced that it will make a contribution of almost EUR 0.25 million to buy back up to 1% of the company’s shares via the Nasdaq stock exchange. The company intends to distribute the purchased shares to employees over the next three years. “In the tourism sector, employees are the backbone of the business. That is why we have clearly identified their engagement and well-being as a priority in Novaturas’ new growth strategy. Stock options are one of the motivational tools that are still rarely used in Lithuania, but are popular abroad and appreciated by employees, which increases engagement, helps retain existing talent and attract new talent. As we are focused on sustainable long-term growth of the company, we grant stock options to Novaturas employees in Lithuania, Latvia and...

Continue reading

RetinalGeniX Technologies Inc. Focuses on Prevention of Blindness and Early Detection of Multiple Systemic Diseases

Video Presentation Highlights Combining Genetic Markers with High-Resolution Retinal Imaging to Aid in Detection and Treatment of Blindness and Multiple Systemic Diseases PETALUMA, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) — RetinalGeniX Technologies Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”) released to the public via OTC Markets, a video webinar regarding the retinal screening medical device technology being developed by the Company to help prevent blindness and multiple systemic diseases, the Company’s business opportunities and the professional background of the Company’s management team. CEO Jerry Katzman, MD, said, “We are no longer just a high-resolution retinal imaging company. This webinar that we posted today should greatly enhance the understanding of the importance of combining genetic markers and high-resolution...

Continue reading

Interim Results for the six months ended 30 June 2023

CAMBRIDGE, United Kingdom, Sept. 18, 2023 (GLOBE NEWSWIRE) — Bango (AIM: BGO), the global platform for data-driven commerce, today announces its interim results for the six months ended 30 June 2023. Key highlights:Revenue up 88% to $20.3M (1H22: $10.8M), in line with management expectations Strong Digital Vending MachineTM (DVM) traction in the US. New deal in 1H means Bango has secured 3 out of 5 key US telcos, opening up subscription bundling to >200M US customers The DOCOMO Digital (DDL) integration cost synergies are 90% complete. On track to deliver profitability in line with consensus expectations.Financial Overview:Results for the 6 months ended 30 June 2023  1H23 1H22 ChangeRevenue $20.3M $10.8M +88%Annual recurring revenue (ARR) 1 $5.6M $3.4M +63%       Adjusted EBITDA2 ($0.2M) $2.9M         Profit/(Loss)...

Continue reading

B2Gold to Consolidate Gramalote Project by Acquiring AngloGold Ashanti’s 50% Stake

VANCOUVER, British Columbia, Sept. 18, 2023 (GLOBE NEWSWIRE) — B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) (“B2Gold” or the “Company”) is pleased to announce that is has entered into a purchase agreement with AngloGold Ashanti Limited (“AngloGold”) to acquire AngloGold’s 50% stake in the Gramalote project (the “Transaction”), located in the Department of Antioquia, Colombia (the “Gramalote Project”). Upon completion of the Transaction, B2Gold will own 100% of the Gramalote Project. Transaction HighlightsConsolidates the Gramalote Project under one owner, providing additional optionality to analyze lower capital intensity, higher-return development opportunities for the Project: Historically, the Gramalote Project has been advanced under a joint venture between B2Gold and AngloGold, which has led to analyzing the project...

Continue reading

Oxurion Receives First EUR 1 Million under Amended Atlas Funding Program

EUR 3.5 Million in Unconditional Funding Allowing Company to Achieve Topline Data from KALAHARI Trial Leuven, BELGIUM, Boston, MA, US – September 18, 2023 – 8 am CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next-generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, has announced the completion of Tranche 5 of funding under the Subscription Agreement with Atlas Special Opportunities LLC (“Atlas”). On September 15, 2023, the Company issued 40 convertible bonds with a value of EUR 1 million to Atlas. This Tranche is the first installment of the EUR 3.5 million in unconditional funding agreed with Atlas allowing the Company to reach the topline data of the Phase 2, Part B of the KALAHARI trial, which is expected by the end of 2023. Under the terms...

Continue reading

Company Update

Vast Resources plc / Ticker: VAST / Index: AIM / Sector: Mining 18 September 2023 Vast Resources plc(‘Vast’ or the ‘Company’) Company Update Vast Resources plc, the AIM-listed mining company, is pleased to announce an update further to the announcement made on 7 August 2023 regarding the recovery of the historic parcel. Due to the recent election process over the course of the past month, the Company has been unable to progress the settlement of the historic parcel as it had expected, however, the Company remains confident of finalising the process and it will report further progress to the market. **ENDS** For further information, visit www.vastplc.com or please contact:Vast Resources plcAndrew Prelea (CEO)Andrew Hall (CCO)www.vastplc.com+44 (0) 20 7846 0974Beaumont Cornish – Financial & Nominated AdvisorRoland CornishJames...

Continue reading

Falcon Oil & Gas Ltd. – Successful Drilling of Shenandoah South 1H Horizontal Well

Falcon Oil & Gas Ltd.(“Falcon”) Successful Drilling of Shenandoah South 1H Horizontal Well 18 September 2023 – Falcon Oil & Gas Ltd. (TSXV: FO, AIM: FOG) is pleased to announce that drilling operations on the Shenandoah South 1H (“SS1H”) well have been successfully completed with Falcon Oil & Gas Australia Limited’s joint venture partner, Tamboran (B2) Pty Limited. The well has been drilled to a total measured depth (“TD”) of 4,300 metres, including a horizontal section over 1,074m in length in the Amungee Member B-shale, with casing and cementing also complete. As noted previously for SS1H:Logging of the Amungee Member B-shale formation indicates potentially higher porosity and gas saturation relative to other wells drilled targeting the same formation.Initial evaluation confirms reservoir continuity of the Amungee...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.